Literature DB >> 1023950

Pancuronium bromide: an indirect sympathomimetic agent.

J S Domenech, R C Garcia, J M Sastain, A Q Loyola, J S Oroz.   

Abstract

In the dog, pancuronium 0.2 mg/kg increased left ventricular systolic pressure and systemic arterial pressure, but did not change central venous pressure. Repeated doses produced diminishing responses and eventually no change in arterial pressure. After tachyphylaxis was established, a pressor response to pancuronium could be induced by an i.v. infusion of noradrenaline. Desipramine, a noradrenaline blocking agent, prevented the restoration of the pressor effect of noradrenaline. Guanethidine and reserpine abollished the restoration of the pressor response to pancuronium by noradrenaline. These findings are consistent with the hypothesis that pancuronium acts on the postganglionic nerve endings and causes release of noradrenaline.

Entities:  

Mesh:

Substances:

Year:  1976        PMID: 1023950     DOI: 10.1093/bja/48.12.1143

Source DB:  PubMed          Journal:  Br J Anaesth        ISSN: 0007-0912            Impact factor:   9.166


  14 in total

1.  Cerebrovascular carbon dioxide reactivity and failure of autoregulation in preterm infants.

Authors:  A C Fenton; K L Woods; D H Evans; M I Levene
Journal:  Arch Dis Child       Date:  1992-07       Impact factor: 3.791

2.  Hemodynamic evaluation of pancuronium and vecuronium by transesophageal echocardiography.

Authors:  S Toyota; M Kaneko; M Kumagai; Y Amaki
Journal:  J Anesth       Date:  1997-06       Impact factor: 2.078

3.  H1 and H2 receptor antagonists and hepatic oxygen supply-demand relationship in pigs.

Authors:  L Roytblat; S Gelman; T Henderson; D Parks
Journal:  Can J Anaesth       Date:  1991-01       Impact factor: 5.063

4.  Potentiation of cardiac sympathetic nerve responses in vivo by pancuronium bromide [proceedings].

Authors:  J R Docherty; J C McGrath
Journal:  Br J Pharmacol       Date:  1977-11       Impact factor: 8.739

5.  Tricyclic antidepressants and cardiac arrhythmias during halothane-pancuronium anesthesia.

Authors:  A Tung; J L Chang; E Garvey; A Bleyaert
Journal:  Anesth Prog       Date:  1981 Mar-Apr

6.  Severe hypertension associated with pancuronium in a patient with a phaeochromocytoma.

Authors:  R M Jones; A B Hill
Journal:  Can Anaesth Soc J       Date:  1981-07

7.  Sympathomimetic effects of pancuronium bromide on the cardiovascular system of the pithed rat: a comparison with the effects of drugs blocking the neuronal uptake of noradrenaline.

Authors:  J R Docherty; J C McGrath
Journal:  Br J Pharmacol       Date:  1978-12       Impact factor: 8.739

8.  Lack of effects of d-tubocurarine and pancuronium on the slow action potential of the guinea pig papillary muscle.

Authors:  H Arimura; Y Ikemoto; T Ito; J Yoshitake
Journal:  Can Anaesth Soc J       Date:  1985-09

9.  A comparison of the effects of pancuronium bromide and its monoquaternary analogue, ORG NC 45, on autonomic and somatic neurotransmission in the rat.

Authors:  J R Docherty; J C McGrath
Journal:  Br J Pharmacol       Date:  1980       Impact factor: 8.739

10.  Difference in the effect of pancuronium and vecuronium on baroreflex control of heart rate in humans.

Authors:  H Tsuchida; S Seki; Y Nakae; A Namiki
Journal:  J Anesth       Date:  1991-07       Impact factor: 2.078

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.